NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT02014129 2020-08-24A Study of LY2835219 in Japanese Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed12 enrolled 11 charts